title: Pharmaceutical Approval Update.
abstract: Lisinopril oral solution (Qbrelis) for the treatment of hypertension, heart failure, and acute myocardial infarction; etanercept-szzs (Erelzi) for multiple autoimmune disorders; and lumacaftor/ivacaftor (Orkambi) for cystic fibrosis.
authors.forename: Michele B
authors.initials: MB
authors.lastname: Kaufman